According to the newspaper Folha de S.Paulo, Brazil‘s National Health Surveillance Agency (Anvisa) approved on Saturday (2) a request from Fiocruz for the exceptional import of 2 million ready-made doses of the vaccine against COVID-19 developed by the University of Oxford and pharmaceutical AstraZeneca.
